Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Pinsky

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimensDaniel W Cramer, Robert C Bast, Christine D Berg, et al.
Annals of Internal Medicine|September 5, 2017
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO TrialsAlex Tsodikov, Roman Gulati, Eveline A M Heijnsdijk, et al.
Annals of Internal Medicine|January 1, 2014
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceHarry J de Koning, Rafael Meza, Sylvia K Plevritis, et al.
Cancer|December 7, 2017
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trialsHarry J de Koning, Roman Gulati, Sue M Moss, et al.
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
The New England Journal of Medicine|May 23, 2012
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopyRobert E Schoen, Paul F Pinsky, Joel L Weissfeld, et al.
JAMA|October 28, 2011
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trialMartin M Oken, Willam G Hocking, Paul A Kvale, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
BJU International|November 28, 2008
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trialRobert L Grubb, Paul F Pinsky, Robert T Greenlee, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimensDaniel W Cramer, Robert C Bast, Christine D Berg, et al.
Annals of Internal Medicine|September 5, 2017
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO TrialsAlex Tsodikov, Roman Gulati, Eveline A M Heijnsdijk, et al.
Annals of Internal Medicine|January 1, 2014
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceHarry J de Koning, Rafael Meza, Sylvia K Plevritis, et al.
Cancer|December 7, 2017
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trialsHarry J de Koning, Roman Gulati, Sue M Moss, et al.
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
The New England Journal of Medicine|May 23, 2012
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopyRobert E Schoen, Paul F Pinsky, Joel L Weissfeld, et al.
JAMA|October 28, 2011
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trialMartin M Oken, Willam G Hocking, Paul A Kvale, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
BJU International|November 28, 2008
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trialRobert L Grubb, Paul F Pinsky, Robert T Greenlee, et al.
Pageof 17